Cutaneous Lymphocytic Vasculitis Due to Ibrutinib Therapy

Cutaneous Lymphocytic Vasculitis Due to Ibrutinib Therapy

Saved in:

Bibliographic Details
Main Authors:	D. Rodriguez-Baeza, E. Pérez-López, C. Román-Curto, A. Santos-Briz
Format:	Article
Language:	English
Published:	Elsevier 2024-11-01
Series:	Actas Dermo-Sifiliográficas
Online Access:	http://www.sciencedirect.com/science/article/pii/S0001731024000437
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

[Artículo traducido] Vasculitis cutánea linfocítica secundaria a tratamiento con ibrutinib
by: D. Rodriguez-Baeza, et al.
Published: (2024-11-01)

Amebic Encephalitis in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib Therapy
by: Ensi Voshtina, et al.
Published: (2018-01-01)

Cutaneous vasculitis in SLE
by: Romy Kallas
Published: (2020-10-01)

Real-world safety profile of therapy with ibrutinib or acalabrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
by: Ramsay Hafer, et al.
Published: (2025-02-01)

Editorial: Cutaneous vasculitis and vasculopathy
by: Erkan Alpsoy, et al.
Published: (2025-02-01)

Mathematical multi-compartment modeling of chronic lymphocytic leukemia cell kinetics under ibrutinib
by: Melanie Schulz, et al.
Published: (2024-12-01)

Recurrent Fibrillary Glomerulonephritis Secondary to Chronic Lymphocytic Leukemia: Remission of Kidney Disease with Ibrutinib
by: Rafeea Shah, et al.
Published: (2024-10-01)

Ibrutinib-Associated Cardiac Tamponade with Concurrent Antiplatelet Therapy
by: Jennifer L. Miatech, et al.
Published: (2020-01-01)

BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
by: Lorenzo Falchi, et al.
Published: (2016-02-01)

Giant Cell Vasculitis and Microscopic (Collagaenous-Lymphocytic) Colitis
by: Hugh J Freeman
Published: (1993-01-01)

Cutaneous Necrotizing Vasculitis and Leukopenia in a Cocaine User: Is Levamisole the Culprit?
by: Lara El Khoury, et al.
Published: (2016-01-01)

The infectious thyroid nodule: a case report of mucormycosis associated with ibrutinib therapy
by: Marco A. Mascarella, et al.
Published: (2019-10-01)

Ibrutinib-associated osteonecrosis of the jaw
by: Annu Singh, et al.
Published: (2024-03-01)

Neutrophil-to-lymphocyte ratio: A biomarker for predicting systemic involvement in iga vasculitis
by: Rintu Merin George, et al.
Published: (2020-01-01)

Hypernephroma Presenting with Cutaneous Leukocytoclastic Vasculitis and Lupus Anticoagulant: Resolution after Nephrectomy
by: Nigel P. Murray, et al.
Published: (2012-01-01)

Pitted Keratolysis Associated With Cutaneous Small-Vessel Vasculitis Resembling Deep Vein Thrombosis
by: Mengyi Zha, et al.
Published: (2025-01-01)

SUCCESSFUL LONG-TERM REMISSION IN AGGRESSIVE YOUNG-ONSET CHRONIC LYMPHOCYTIC LEUKEMIA WITH IBRUTINIB AND VENETOCLAX: A DECADE-LONG CASE STUDY
by: Naciye Nur Tozluklu, et al.
Published: (2024-12-01)

Major hemorrhage in chronic lymphocytic leukemia patients in the US Veterans Health Administration system in the pre‐ibrutinib era: Incidence and risk factors
by: Peter Georgantopoulos, et al.
Published: (2019-05-01)

A Rare Case of Ixazomib-Induced Cutaneous Necrotizing Vasculitis in a Patient with Relapsed Myeloma
by: Heather Katz, et al.
Published: (2019-01-01)

Toxicity and Dermatokinetic Analysis of Ibrutinib in Human Skin Models
by: Maria Victória Souto-Silva, et al.
Published: (2024-10-01)

Prolonged remission with ibrutinib maintenance therapy following radiation in a patient with relapsed primary CNS lymphoma
by: Steven Du, et al.
Published: (2024-12-01)

Leukocytoclastic Vasculitis as a Cutaneous Manifestation of COVID-19 Infection with a Positive Skin Antigen Test
by: Oghowan Abdelrahman, et al.
Published: (2021-04-01)

A Rare Cutaneous Manifestation: Leukocytoclastic Vasculitis after Pfizer-BioNTech COVID-19 Vaccination
by: Yaritza Serrano Gomez, et al.
Published: (2022-01-01)

Systemic Levamisole-Induced Vasculitis in a Cocaine User without Cutaneous Findings: A Consideration in Diagnosis
by: Gillian G. Baptiste, et al.
Published: (2015-01-01)

Rapid Growth of Lung Nodules due to Combined Pulmonary Vasculitis, Silicoanthracosis, and Chondrocalcinosis
by: Wolfgang Jungraithmayr, et al.
Published: (2016-01-01)

High incidence of atrial fibrillation in patients treated with ibrutinib
by: Florian Baptiste, et al.
Published: (2019-05-01)

A Case of Bing–Neel Syndrome Successfully Treated with Ibrutinib
by: Daniel S. O’Neil, et al.
Published: (2018-01-01)

Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL
by: Lavinia Arseni, et al.
Published: (2025-01-01)

Intravenous γ Globulin for Intractable Abdominal Pain due to IgA Vasculitis
by: George Naifa, et al.
Published: (2020-01-01)

Epidemiology, clinical characteristics and potential mechanism of ibrutinib-induced ventricular arrhythmias
by: Yilin Pan, et al.
Published: (2024-11-01)

İbrutinib Sonrası Gelişen Dev Ekimoz ve Hematom: Olgu Sunumu
by: Aynur Uğur Bilgin, et al.
Published: (2017-03-01)

HSV-1 Encephalitis in an Elderly Man Receiving Ibrutinib for Waldenstrom’s Macroglobulinemia
by: Mark R. Wallace
Published: (2020-01-01)

Failure of Recombinant Activated Factor VII in Treatment of Diffuse Alveolar Hemorrhage due to Cryoglobulinemic Vasculitis
by: Dania Khoulani, et al.
Published: (2014-01-01)

Vasculitis in Children
by: Yağmur Bayındır, et al.
Published: (2024-11-01)

Ibrutinib associated cardiovascular events in a patient wearing an implanted loop recorder
by: Daniel Rivera, et al.
Published: (2021-06-01)

Enhancement of oral bioavailability of ibrutinib using a liposil nanohybrid delivery system.
by: Fareeaa Ashar, et al.
Published: (2024-01-01)

Phase I study of pembrolizumab in combination with ibrutinib for the treatment of unresectable or metastatic melanoma
by: Yuan Yao, et al.
Published: (2025-02-01)

Hearing Loss due to Infiltration of the Tympanic Membrane by Chronic Lymphocytic Leukemia
by: Jonathon B. Cohen, et al.
Published: (2012-01-01)

Histopathological Patterns of Cutaneous and Mucocutaneous Leishmaniasis Due to L. aethiopica
by: Abay Atnafu, et al.
Published: (2024-01-01)

Ibrutinib disrupts blood-tumor barrier integrity and prolongs survival in rodent glioma model
by: Sanghee Lim, et al.
Published: (2024-04-01)